UPDATE: Ligand Pharmaceuticals Posts In-Line Q4 Earnings, Issues Weak Outlook

By: via Benzinga
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) reported in-line earnings for the fourth quarter. The La Jolla, California-based company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.